Home
FATE
FATE News

Latest Fate Therapeutics Inc. (FATE) News on July 27, 2024

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

Motley Fool

6 days ago

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

24 days ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

a month ago

Piper Sandler Upgrades Fate Therapeutics to Overweight From Neutral, Adjusts Price Target to $6 From $4

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a month ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a month ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a month ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

a month ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a month ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

a month ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

a month ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

a month ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference

Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript

Insider Monkey

2 months ago

Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript

Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

3 months ago

Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

GuruFocus.com

3 months ago

Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...

MT Newswires

3 months ago

Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating

MT Newswires

3 months ago

Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Fate Therapeutics: Q1 Earnings Snapshot

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire

3 months ago

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program

GlobeNewswire

3 months ago

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates

GlobeNewswire

3 months ago

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

GlobeNewswire

3 months ago

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

GlobeNewswire

3 months ago

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress

Zacks

4 months ago

Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?

Zacks

4 months ago

Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?

Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?

Zacks

4 months ago

Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?

Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

GlobeNewswire

4 months ago

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript

Fate Therapeutics to Present at Upcoming March Investor Conferences

GlobeNewswire

5 months ago

Fate Therapeutics to Present at Upcoming March Investor Conferences

Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.

5 months ago

Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets

Fate Therapeutics Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

5 months ago

Fate Therapeutics Full Year 2023 Earnings: EPS Beats Expectations

Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y

Zacks

5 months ago

Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Fate Therapeutics Inc Earnings Call

Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates

GuruFocus.com

5 months ago

Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results

Associated Press Finance

5 months ago

Fate Therapeutics: Q4 Earnings Snapshot

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

GlobeNewswire

5 months ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

13 Best Booming Stocks to Buy Right Now

Insider Monkey

5 months ago

13 Best Booming Stocks to Buy Right Now

Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

5 months ago

Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

5 months ago

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

5 months ago

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

SunOpta (STKL) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

6 months ago

SunOpta (STKL) Stock Falls Amid Market Uptick: What Investors Need to Know

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics (FATE) Soars 25.4%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Fate Therapeutics (FATE) Soars 25.4%: Is Further Upside Left in the Stock?

PacWest Bancorp (NASDAQ:PACW) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

PacWest Bancorp (NASDAQ:PACW) Q4 2023 Earnings Call Transcript

Here's Why We're Wary Of Buying Donegal Group's (NASDAQ:DGIC.A) For Its Upcoming Dividend

Simply Wall St.

6 months ago

Here's Why We're Wary Of Buying Donegal Group's (NASDAQ:DGIC.A) For Its Upcoming Dividend

The Manitowoc Company, Inc. (MTW) Increases Despite Market Slip: Here's What You Need to Know

Zacks

6 months ago

The Manitowoc Company, Inc. (MTW) Increases Despite Market Slip: Here's What You Need to Know

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

Simply Wall St.

6 months ago

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Energy Recovery to Release Full Year and Fourth Quarter 2023 Financial Results

Business Wire

6 months ago

Energy Recovery to Release Full Year and Fourth Quarter 2023 Financial Results

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

StockStory

6 months ago

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

The Rental Market Rebound: The 5 Largest Apartment REITs to Consider in 2024

Benzinga

6 months ago

The Rental Market Rebound: The 5 Largest Apartment REITs to Consider in 2024

NGL Energy Partners LP Announces $700 Million Senior Secured Term Loan Facility and Provides Financial Update

Business Wire

6 months ago

NGL Energy Partners LP Announces $700 Million Senior Secured Term Loan Facility and Provides Financial Update

2 Industrial REITs to Buy for Income in 2024

Benzinga

6 months ago

2 Industrial REITs to Buy for Income in 2024

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Motley Fool

6 months ago

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

PureCycle Provides Ironton Purification Facility Production Update

ACCESSWIRE

6 months ago

PureCycle Provides Ironton Purification Facility Production Update

AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares

GuruFocus.com

6 months ago

AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares

Business Wire

6 months ago

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program’s Inception

Edgewell Personal Care Company to Webcast a Discussion of First Quarter Fiscal Year 2024 Results on February 7, 2024

PR Newswire

7 months ago

Edgewell Personal Care Company to Webcast a Discussion of First Quarter Fiscal Year 2024 Results on February 7, 2024

Planet to Participate in Upcoming Investor Conferences

Business Wire

7 months ago

Planet to Participate in Upcoming Investor Conferences

Pricesmart Inc (PSMT) Reports Strong Growth in Q1 Fiscal 2024

GuruFocus.com

7 months ago

Pricesmart Inc (PSMT) Reports Strong Growth in Q1 Fiscal 2024

SAVE THE DATE: NOVAGOLD 2023 Year-End Financial Results Release, Conference Call and Video Webcast

GlobeNewswire

7 months ago

SAVE THE DATE: NOVAGOLD 2023 Year-End Financial Results Release, Conference Call and Video Webcast

Metal credit cards explainer: What are they and how do they work?

Yahoo Personal Finance

7 months ago

Metal credit cards explainer: What are they and how do they work?

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

GlobeNewswire

7 months ago

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

While individual investors own 30% of Magic Software Enterprises Ltd. (NASDAQ:MGIC), public companies are its largest shareholders with 46% ownership

Simply Wall St.

7 months ago

While individual investors own 30% of Magic Software Enterprises Ltd. (NASDAQ:MGIC), public companies are its largest shareholders with 46% ownership

Camden National (NASDAQ:CAC) Will Pay A Dividend Of $0.42

Simply Wall St.

7 months ago

Camden National (NASDAQ:CAC) Will Pay A Dividend Of $0.42

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

GuruFocus.com

7 months ago

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

Is Global Partners (GLP) Stock Undervalued Right Now?

Zacks

7 months ago

Is Global Partners (GLP) Stock Undervalued Right Now?

Himax Teams Up with DESMAN to Unveil Revolutionary High-End Smart Door Locks at CES 2024

GlobeNewswire

7 months ago

Himax Teams Up with DESMAN to Unveil Revolutionary High-End Smart Door Locks at CES 2024

Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023

InvestorPlace

7 months ago

Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023

Camden National Corporation to Announce Quarter and Year Ended December 31, 2023 Financial Results on January 30, 2024

PR Newswire

7 months ago

Camden National Corporation to Announce Quarter and Year Ended December 31, 2023 Financial Results on January 30, 2024

Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.

GlobeNewswire

7 months ago

Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.

Zhihu Inc.'s (NYSE:ZH) Intrinsic Value Is Potentially 55% Above Its Share Price

Simply Wall St.

7 months ago

Zhihu Inc.'s (NYSE:ZH) Intrinsic Value Is Potentially 55% Above Its Share Price

Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase

Simply Wall St.

7 months ago

Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase

Stratasys (SSYS) Gets Unsolicited Proposal From Nano Dimension

Zacks

7 months ago

Stratasys (SSYS) Gets Unsolicited Proposal From Nano Dimension

Why Is 3D Printing Solutions Provider Stratasys Stock Soaring Today?

Benzinga

7 months ago

Why Is 3D Printing Solutions Provider Stratasys Stock Soaring Today?

11 Best Nickel Stocks to Buy Now

Insider Monkey

7 months ago

11 Best Nickel Stocks to Buy Now

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

Zacks

7 months ago

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem

GlobeNewswire

7 months ago

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem

Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

12 Most Promising Cancer Stocks According to Analysts

Insider Monkey

7 months ago

12 Most Promising Cancer Stocks According to Analysts

PureCycle Provides Ironton Operations Update

ACCESSWIRE

7 months ago

PureCycle Provides Ironton Operations Update

9 Best Cobalt Stocks to Buy Now

Insider Monkey

7 months ago

9 Best Cobalt Stocks to Buy Now

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Business Wire

7 months ago

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UWM Holdings (NYSE:UWMC) Has Affirmed Its Dividend Of $0.10

Simply Wall St.

7 months ago

UWM Holdings (NYSE:UWMC) Has Affirmed Its Dividend Of $0.10

12 Best Junior Silver Mining Stocks To Buy Now

Insider Monkey

8 months ago

12 Best Junior Silver Mining Stocks To Buy Now

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting

GlobeNewswire

8 months ago

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting

Fate Therapeutics (FATE) Up 10.3% Since Last Earnings Report: Can It Continue?

Zacks

8 months ago

Fate Therapeutics (FATE) Up 10.3% Since Last Earnings Report: Can It Continue?

Why Is B&G Foods (BGS) Up 16.9% Since Last Earnings Report?

Zacks

8 months ago

Why Is B&G Foods (BGS) Up 16.9% Since Last Earnings Report?

Investors in Kornit Digital (NASDAQ:KRNT) have unfortunately lost 78% over the last three years

Simply Wall St.

8 months ago

Investors in Kornit Digital (NASDAQ:KRNT) have unfortunately lost 78% over the last three years

PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023

Business Wire

8 months ago

PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023

30 Most Profitable Online Businesses To Start In 2024

Insider Monkey

8 months ago

30 Most Profitable Online Businesses To Start In 2024

Should Investors Hold on to Essex Property (ESS) Stock Now?

Zacks

8 months ago

Should Investors Hold on to Essex Property (ESS) Stock Now?

Share on Social Networks: